Advanced search
Publication Cover
Leukemia & Lymphoma Volume 43, 2002 - Issue 11
Submit an article Journal homepage
785
Views
34
CrossRef citations to date
0
Altmetric
Research Article

A Novel B-cell Line (U-2932) Established from a Patient with Diffuse Large B-cell Lymphoma Following Hodgkin Lymphoma

Rose-Marie Amini Department of Genetics and Pathology, Uppsala University, Uppsala University Hospital, SE-751 85 Uppsala, Sweden; Department of Oncology, Radiology and Clinical Immunology, Uppsala University, Uppsala University Hospital, SE-751 85 Uppsala, Sweden
,
Mattias Berglund Department of Oncology, Radiology and Clinical Immunology, Uppsala University, Uppsala University Hospital, SE-751 85 Uppsala, Sweden; Endocrine Tumor Unit, Department of Molecular Medicine, CMML8:01, Karolinska Institute and Hospital, Stockholm, Sweden
,
Richard Rosenquist Department of Oncology, Radiology and Clinical Immunology, Uppsala University, Uppsala University Hospital, SE-751 85 Uppsala, Sweden; Department of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden
,
Anne von Heideman Department of Oncology, Radiology and Clinical Immunology, Uppsala University, Uppsala University Hospital, SE-751 85 Uppsala, Sweden
,
Svetlana Lagercrantz Endocrine Tumor Unit, Department of Molecular Medicine, CMML8:01, Karolinska Institute and Hospital, Stockholm, Sweden
,
Ulf Thunberg Department of Oncology, Radiology and Clinical Immunology, Uppsala University, Uppsala University Hospital, SE-751 85 Uppsala, Sweden
,
Jonas Bergh Department of Oncology, Radiumhemmet, Karolinska Institute and Hospital, Stockholm, Sweden
,
Christer Sundström Department of Genetics and Pathology, Uppsala University, Uppsala University Hospital, SE-751 85 Uppsala, Sweden
,
Bengt Glimelius Department of Genetics and Pathology, Uppsala University, Uppsala University Hospital, SE-751 85 Uppsala, Sweden
&
Gunilla Enblad Department of Oncology, Radiology and Clinical Immunology, Uppsala University, Uppsala University Hospital, SE-751 85 Uppsala, Sweden
 show all
Pages 2179-2189 | Published online: 01 Jul 2009

  • Harris, N.L., Jaffe, E.S., Stein, H., Banks, P.M., Chan, J.K.C., Cleary, M.L., Delsol, G., De Wolf-Peeters, C., Falini, B., Gatter, K.C., Grogan, T.M., Isaacson, P.G., Knowles, D.M., Mason, D.Y., Muller-Hermelink, H.-K., Pileri, S.A., Piris, M.A., Ralfkiaer, E. and Wamke. R.A. (1994) "A revised European-American classification of lymphoid neoplasms: a proposal from the international lymphoma study group", Blood 84, 1361-1392.
  • Jaffe, E.S., Harris, N.L., Stein, H. and Vardiman, J.W. (2001) Pathology and Genetics of Tumours of Haematopoietic and Lymphoid tissues. World Health Organization Classification of Tumours (IARC Press, Lyon).
  • Jaffe, E.S., Zarate-Osomo, A., Kingma, D.W., Raffeld, M. and Medeiros, L.J. (1994) "The interrelationship between Hodgkin's disease and non-Hodgkin's lymphomas", Annals of Oncology 5, 7-11.
  • Amini, R.-M., Enblad, G., Sundström, C. and Glimelius, B. (1997) "Patients suffering from both Hodgkin's disease and non-Hodgkin's lymphoma: a clinicopathological and immuno-histochemical population-based study of 32 patients", International Journal of Cancer 71, 510-516.
  • Brauninger, A., Hansmann, M.L., Strickler, J.G., Dummer, R., Burg, G., Rajewsky, K. and Küppers, R. (1999) "Identification of common germinal-center B-cell precursors in two patients with both Hodgkin's disease and non-Hodgkin's lymphoma", New England Journal of Medicine 340, 1239-1247.
  • Küppers, R., Sousa, A.B., Baur, A.S., Strickler, J.G., Rajewsky, K. and Hansmann, M.-L. (2001) "Common germinal-center B-cell origin of the malignant cells in two composite lymphomas, involving classical Hodgkin's disease and either follicular lymphoma or B-CLL", Molecular Medicine 7, 285-292.
  • Rueffer, U., Josting, A., Franklin, J., May, M., Sieber, M., Breuer, K., Engert, A. and Deihl, V. (2001) "Non-Hodgkin's lymphoma after primary Hodgkin's disease in the German Hodgkin's Lymphoma Study Group: incidence, treatment, and prognosis", Journal of Clinical Oncology 19, 2026-2032.
  • Diehl, V. and Josting, A. (2000) "Hodgkin's disease", Cancer Journal 6, 150-158.
  • Amini, R.-M., Enblad, G., Gustavsson, A., Ekman, T., Erlanson, M., Haapaniemi, E. and Glimelius, B. (2000) "Treatment outcome in patients younger than 60 years with advanced stages (HB-IV) of Hodgkin's disease: the Swedish National Health Care Programme experience", European Journal of Haematology 65, 379-389.
  • Brandt, L., Kimby, E., Nygren, P. and Glimelius, B. (2001) "A systematic overview of chemotherapy effects in Hodgkin's disease", Acta Oncologica 41, 185-197.
  • Kimby, E., Brandt, L., Nygren, P. and Glimelius, B. (2001) "A systematic overview of chemotherapy effects in aggressive non-Hodgkin's lymphoms", Acta Oncologica 40, 198-212.
  • Jerkeman, M., Anderson, H. Cavallin-Ståhl, E., Dictor, M., Hagberg, H., Johnson, A., Kaasa, S., Kvaloy, S., Sundström, C. and Åkerman, M. (1999) "CHOP versus MACOP-B in aggressive lymphoma-a Nordic Lymphoma Group randomized trial", Annals of Oncology 10, 1079-1086.
  • Amini, R.-M., Glimelius, B., Gustavsson, A., Ekman, T., Erlanson, M., Haapaniemi, E. and Enblad, G. (2001) "A population-based study of the outcome for patients with first relapse of Hodgkin's lymphoma", European Journal of Haematology, In press.
  • Piris, M.A., Pezella, F., Martinez-Montero, J.C., Orradre, J.L., Viluendas, R., Sanchez-Beato, M., Cuena, R., Cruz, M.A., Martinez, B., Garrido, M.C., Gatter, K., Aiello, A., Delia, D., Giardini, R. and Rilke, F. (1994) "p53 and bcl-2 Expression in high-grade B-cell lymphomas. Correlation with survival time", British Journal of Cancer 69, 337-341.
  • Wilson, W.H., Teruya-Feldstein, J., Fest, T., Harris, C., Steinberg, S.M., Jaffe, E.S. and Raffeld, M. (1997) "Relationship of p53, bcl-2 and tumor proliferation to clinical drug resistance in non-Hodgkin's lymphoma", Blood 89, 601-609.
  • Newcomb, E. (1995) "p53 Gene mutations in lymphoid diseases and their possible relevance to drug resistance", Leukemia and Lymphoma 17, 211-221.
  • Amini, R.-M., Enblad, G., Engström, P., Christensson, B. and Sundström, C. (2002) "Relapsed Hodgkin's lymphoma: immunostaining patterns in relation to survival", Leukemia and Lymphoma 43, 1253-1260.
  • [181 Li, A.M., Rosenquist, R., Forestier, E., Holmberg, D., Lindh, J., Löfvenberg, F., and Roos, G. (1999) "Clonal rearrangements in childhood and adult precursor B acute lympboblastic leukemia; a comparative polymerase chain reaction study using multiple sets of primers", European Journal of Haematology 63, 211-218.
  • Thunberg, U., Rosenquist, R., Lindström, A., Lindh, J., Sundström, C., Roos, G. and Sällström, J. (1997) "Comparative analysis of detection systems for evaluation of PCR amplified immunoglobulin heavy-chain gene rearrangements", Diagnostic Molecular Pathology 6, 140-146.
  • Hamblin, T.J., Davis, Z., Gardiner, A., Oscier, D.G. and Stevenson, F.K. (19991 "Unmutated Ig V (H) genes are associated with a more aggressive form of chronic lymphocytic leukemia", Blood 94, 1848-1854.
  • Thunberg, U., Johnson, A., Roos, G., Thörn, I., Tobin, G., Sällström, J., Sundström, C. and Rosenquist, R. (2001) "CD38 expression is a poor predictor for VH gene mutational status and prognosis in chronic lymphocytic leukemia", Blood 97. 1892-1893.
  • Lossos, I.S., Alizadeh, A.A., Eisen, M.B., Chan, W.C., Brown, P.O., Botstein, D., Staudt, L.M. and Levy, R. (2000) "Ongoing immunoglubulin somatic mutation in germinal center B cell-like but not in activated B cell-like diffuse large cell lymphomas", Proceedings of the National Academy of Sciences of the United States of America 97, 10209-10213.
  • Bergh, J., Norberg, T. Sjögren, S., Lindgren, A. and Holmberg, L. (1995) "Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in the relation to adjuvant systemic therapy and radiotherapy", Nature Medicine 1, 1029-1034.
  • Sjögren, S., Inganäs, M., Norberg, T., Lindgren, A., Nordgren, H., Holmberg, L. and Bergh, J. (1996) "The p53 gene in breast cancer: Prognostic value of complementary DNA sequencing versus immunohistochemistry", Journal of National Cancer Institute 88, 173-182.
  • Ståhl, S., Hultman, T., Olsson, A., Moks, T. and Uhlen, M. (1988) "Solid phase DNA sequencing using the biotin-avidin system", Nuclear Acids Research 16, 3025-3038.
  • Mitelman, F., ed, (1995) ISCN: International System for Human Cytogenetic Nomenclature (S. Karger, Basel).
  • Alizadeh, A.A., Eisen, M.B., Davis, R.E., Ma, C., Lossos, I.S., Rosenwald, A., Boldrick, J.C., Sabel, H., Tran, T., Yu, X., Powell, J.I., Yang, L., Marli, G.E., Moore, T., Hudson, J., Lu, L., Lewis, D.B., Tibshirani, R., Sherlock, G., Chan, W.C., Greiner, T.C., Weisenburger, D.D., Armitage, J.O., Warnke, R., Levy, R., Wilson, W., Grever, M.R., Byrd, J.C., Botstein, D., Brown, P.O. and Staudt, L.M. (2000) "Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling", Nature 403, 503-511.
  • Skinnider, B.F., Horsman, D.E., Dupuis, B. and Gascoyne, R.D. (1999) "Bcl-6 and Bcl-2 protein expression in diffuse large B-cell lymphoma and follicular lymphoma: correlation with 3q27 and 18q21 chromosomal abnormalities", Human Pathology 30, 803-808.
  • Monni, O., Joensuu, H., Franssila, K., Klefstrom, J., Alitalo, K. and Knuutila, S. (1997) "BCL 2 overexpression associated with chromosomal amplification in diffuse large B-cell lymphoma", Blood 90, 1168-1174.
  • Thangavelu, M. and Le Beau, M.M. (1989) "Chromosomal abnormalities in Hodgkin's disease", Hematology/Oncology Clinics of North America 3, 221-236.
  • Weber-Matthiesen, K., Deerberg, J., Poetsch, M., Grote, W. and Schlegelberger, B. (1995) "Numerical chromosome aberrations are present within the CD30+ Hodgkin and Reed-Stemberg cells in 100% of analyzed cases of Hodgkin's disease", Blood 86, 1464-1468.
  • Obshima, K., Ishiguro, M., Ohgami, A., Sugihara, M., Haraoka, S., Suzumiya, J. and Kikuchi, M. (1999) "Genetic analysis of sorted Hodgkin and Reed-Sternberg cells using comparative genomic hybridization", International Journal of Cancer 82, 250-255.
  • Falzetti, D., Crescenzi, B., Matteucci, C., Falini, B., Martelli, M.F., Van den Berghe, H. and Mecucci, C. (1999) "Genomic instability and recurrent breakpoints are main cytogenetic findings in Hodgkin's disease", Haematologica 84, 298-305.
  • Drexler, H.G. and Minowada, J. (1992) "Hodgkin's disease derived cell lines: a review", Human Cell 5, 42-53.
  • Offit, K., Jhanwar, S.C., Ladanyi, M., Filippa, D.A. and Chaganti, R.S.K. (1991) "Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin's lymphoma", Genes. Chromosomes and Cancer 3, 189-201.
  • Merup, M., Calero Moreno, T., Heyman, M., Rönnberg, K., Grander, D., Detlofsson, R., Rasool, O., Liu, Y., Söderhäll, S., Juliusson, G., Gahrton, G. and Einhorn, S. (1998) "6q Deletions in acute lymphoblastic leukemia and non-Hodgkin's lymphoma", Blood 91, 3397-3400.
  • Guan, X.Y., Horsman, D., Zhang, H.E., Parsa, N.Z., Meltzer, P.S. and Trent, J.M. (1996) "Localization by chromosome microdissection of a recurrent breakpoint region on chromosome 6 in human B-cell lymphoma", Blood 88, 1418-1422.
  • Stilgenbauer, S., Liebisch, P., James, M.R., Schröder, M., Schlegelberger, B., Fischer, K., Bentz, M., Lichter, P. and Döhner, H. (1996) "Molecular cytogenetic delineation of a novel critical genomic region in chromosome bands 11q22.3-q23.1 in lymphoproliferative disorders", Proceedings of the National Academy of Sciences of the United States of America 93 11837-11841.
  • Nordgren, A., Sorensen, A.-G., Tinggaard-Pedersen, N., Blennow, E., Larsson, C. and Lagercrantz, S. (2000) "New chromosomal breakpoints in non-Hodgkin's lymphomas revealed by spectral karyotyping and G-banding", International Journal of Molecular Medicine 5.485-492.
  • Robles, A.I. and Harris, C.C. (2001) "p53-Mediated apoptosis and genomic instability diseases", Acta Oncologica 40, 696-701.
  • Villuendas, R., Piris, M.A., Algara, P., Sanchez-Beato, M., Sanches-Verde, L., Martinez, J.C., Orradre, J.L., Garcia, P., Lopez, C. and Martinez, P. (1993) "The expression of p53 protein in non-Hodgkin's lymphomas is not always dependent on p53 gene mutations", Blood 82, 3151-3156.
  • Navaratnam, S., Williams, G.J., Rubinger, M., Pettigrew, N.M., Mowat, M.R., Begleiter, A. and Johnston, J.B. (1998) "Expression of p53 predicts treatment failure in aggressive non-Hodgkin lymphomas", Leukemia and Lymphoma 29, 139-144.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.